The kallikreins have been shown to be potentially useful prognostic markers in ovarian cancer [31,32] and laminin γ2 and MUC5B were shown to display high expression among some of the cancers at the protein level as well, using Western analyses (Figure 6). This evidence concerns the gene MUC5B and ovarian carcinoma.